Clinical Trial Update: Levetiracetam for Persons at Risk for Alzheimer's Disease [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 study of levetiracetam for individuals at risk of Alzheimer's disease. The study is currently recruiting at Sunnybro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Hippocampal Hyperactivation, Prodromal Alzheimer Disease | Phase 2 | Status: RECRUITING